From Our Blog

CMS’s (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions

SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that the preclinical results

Continue readingCMS’s (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions

From Coding Between Orders to a Full Software Ecosystem: Charlotte-Area Black Founder Has Spent Nearly Two Decades Building Technology for the Small Operator

What began in 2008 as a self-taught faith leader building streaming tools so churches could reach wider audiences has grown

Continue readingFrom Coding Between Orders to a Full Software Ecosystem: Charlotte-Area Black Founder Has Spent Nearly Two Decades Building Technology for the Small Operator